1 - PDF 免费下载

.................................. 1............................................. 2............................................. 4........................................... 6...................................................... 6............................................................. 7........................................................ 8............................................................ 9............................................ 10........................ 10.................... 11...................................... 12...... 12.......................... 13.......................................... 15............................ 16.................................. 17.................................. 18................................ 19................................ 20 93........................ 21........ 24.............. 26................ 31.................................. 36.................................. 40.......................... 45.................... 47............................ 48................................ 50.......................................... 52 2

..................... 54................................................ 54.................... 55................................................ 56...................... 57........ 57...................................... 58...................................... 59...................................... 63........................................ 64............................................ 65.......................................... 66.................... 68............................ 70........................................ 72...................................... 72.................. 74.............. 74.................................... 75................................................ 75........................................ 76............................................ 77............................................ 80.......................................... 83.................................. 86............................ 86.................... 91.................................. 92................................ 94.............................. 94...................................... 95........................................ 96............................ 97......................................... 98 3

93 43 24.5% 34 19% 33 19% 43 24.5% 23 13% 176 93 49 28% 105 60% 22 12% 176 93 104,828 29% 51,136 15% 87,485 25% 63,509 18% 37,813 11% 6,363 2% 93 351,134 6

93 427 41% 457 43% 93 9% 77 7% 1,054 93 93 427 427 93 78,386 3% 92,513 4% 178,668 8% 431,073 19% 946,943 41% 324,192 14% 20,633 1% 221,333 10% 93 2,293,741 7

93 9 25% 9 25% 10 28% 8 22% 36 93 13,866 21% 25,700 38% 15,535 23% 12,343 18% 93 67,444 8

93 8 24% 5 15% 20 61% 33 93 17,203 28% 8,733 14% 34,588 58% 93 60,524 9

93 93 7 10 93 93 9 3 93 9 10

WIN Aw a r d WIN Global 10 WIN Japan WIN Award 1996 WIN Global 8 2004 5 WIN Ta i w a n 14 WIN Aw a r d WIN Global WIN Global WIN Award 11

95 1. 2. 9 3 8 9 1986 S u r r y 12

93 1 93 2 4 9 3 4 L M - - 93-13 13

L M - - 93-23 A N - L M - 93-006 8 3 1 93 9 3 0930031290 9 11 14

93 10 18 19 4 3 19 200 ICRP 2005 IRPA-11 Lessons learned from IRPA 11 Radiation Protection Standards: Now and the Future Radiation Safety for the Design and Operation of Particle Accelerators Brookhaven Technical Basis Document for Internal Dosimetry and Urine Bioassay Programs Perspectives of Managing Radiation Protection in United States The Dose Reduction Strategy and ALARA Trend of Nuclear Power Plants in Taiwan ALARA Radiation Dose Reduction Measures on Management Perspectives 15

93 1 0 2 9 16

30 93 3 1 93 1 2 203 17

3 3 3 18 112 1 3 18

93 3 1 0 5 92 2 1 71 19

91 1 1 93 3 1 20

93 8 3 0 9 2 4 21

250 9 2 0 9 2 2 9 23 22

9 2 4 9 3 1, 200 93 93 6. 2 % 5. 4 % 4. 8 % 7. 2 % 23

5 6 6 24

24 93 1 1 2 4 12 93 1 2 1 3 24 20 31 19 2,210 9 4 25

S c h i z o p h r e n i a Alzheimer's disease Parkinson's disease Positron Emission To m o g r a p h y, P E T S i n g l e - Photon Emission Computed To m o g r a p h y, SPECT 93 FDDNP amyloid beta plaques F D D N P 2 -( 1, 1 - d i c y a n o p r o p e n - 2 - y l )- 6 -[( 2 - fluoroethyl) methylamino] naphthalene 92 F D D N P TsDDNP 200 mg 95 % 93-18 - 18 C8 Sep-Pa k column - 18 - F D D N P H P L C 26

T L C - 18 - F D D N P m C i 20 ~ 30 % T L C 85 % - 18 - F D D N P - 18 - F D D N P PET -123-ADAM s e r o t o n i n synaptic cleft - 123 S P E C T - 124 P E T A D A M ( 2 -[[ 2 -[( d i m e t h y l a m i n o ) m e t h y l ] p h e n y l ] t h i o ]- 5 - i o d o p h e n y p a m i n e ) S n A D A M [ 2 -(( 2 - a m i n o - 4 - t r i - n - butyltinphenyl) thio)benzyl] dimethylamine S n A D A M 300 mg 95 % - 123-124 - S n A D A M 5 % p H C 8 I - 123 - ADAM 50 mci 40% HPLC 90 % 48-99m-TRODAT-1 Parkinson's Disease d o p a m i n e - 99 m - T R O D AT- 1 (2beta-((N,N'-bis(2-mercaptoethyl) ethylene 27

diamino)methyl), 3beta-(4-chlorophenyl)tropane) - 99 m - T R O D AT- 1-99 m 136931-99 m - T R O D AT- 1 6 90 % 4 100 6. 5-8. 5 > 90 % < 35 E U / m l 91 11 93 3-123-MIPP ( R )- N - m e t h y l - 3 -( 2 - iodophenoxy)- 3-phenylpropanamine M I P P n i s o x e t i n e ( R )-[ I - 123 ] M I P P ( S )-(-)- 3 - c h l o r o - 1 - p h e n l y p r o p a n o l t r i p h e n y l p h o s p h i n e diethyl azodicarboxylate 2 - b r o m o p h e n o l M i t s u n o b u ( R )- M B P P ( R ) - [ I - 1 2 3 ] M I P P ( R ) - M B P P M S P P ( R )- N - methyl-3-(2-tributylstannylphenoxy)- 3-phenylpropanamine MSPP - 123 - M I P P M S P P ( R ) - M I P P M I P P M B P P M S P P - 123 94-123-MIPP 28

-123-IBZM D2 r e c e p t o r To u r e t t e ' s s y n d r o m e D2 D2 r e c e p t o r D2 receptor occupancy - 123 I B Z M ( ( S )-(-) - 2 - h y d r o x y - 3 - i o d o - 6 - m e t h o x y - N -[( 1 - e t h y l - 2 - p y r r o l i d i n y ) m e t h y l ] benzamide) IBZM ph 4 e l e c t r o p h i l i c - 123 B Z M Accubound C-8 54-62% T L C I B Z M 95 % - 123 I B Z M 0. 2 m M i l l i p o r e - 99 m - T R O D AT- 1-123 - I B Z M PARKINSON S DISEASE MSA ESSENTIALTREMOR TRODAT-1 IBZM -99m-TRODAT-1-123-IBZM 29

93-18 - F D G m i c r o P E T - 99 m - H M PAO m i c r o S P E C T - 18 - F D G %ID/g 0.50 A B 0-18-FDG micropet A. -18-FDG B. -18-FDG 30

m i c r o P E T m i c r o S P E C T / C T m i c r o P E T m i c r o S P E C T PET S P E C T Probabilistic Risk Assessment, PRA 93 6 8 Nucleonics We e k Inside NRC I A E A 2004 Risk Monitors 2004 1 20 12 31

T I R M - 2 I A E A T I R M - 2 P R A P R A What can go wrong? How likely is it? What are the consequences? P R A 74 P R A 76 80 P R A P R 76 P R A 90 3 1 8 14 3 A P R A 84 86 P R A P R A P R A TIRM-2 CDF LERF I N E R F T 1960 32

F TA 1970 P R A 7 5 INERFT F TA P R A F TA P R A 85 P R A P R A P R A P R A 91 5 I N E R F T 92 3 P R A P R A 90 1 2 33

9 1 4 P R A P R A P R A 93 1 2 2 0 P R A / Q R A P R A M I T G e o r g e A p o s t o l a k i s P R A 120 N A S A P R A P R A 34

921 10CFR50 Appendix R P R A P R A 90 3 1 8 3 A P R A P R A 94 P R A 35

PRA Plasma Thermal plasma Cold plasma 10, 000 1, 400 ~ 1, 650 1980 82 7 20 3, 000 55 2005 3, 000 70 36

kw INER-20RF 20 1993~1994 INER-100NT 100 1994~1996 INER-1200T 1,200 1996~1998 INER-10NT 10 2000~2001 INER-1000NT 1,000 2003 INER-3000NT 3,000 2004~2005 INER-3000T 3,000 2005~2006 INER-PF10 100 kw 2 10 1995~1996 INER-PF250 INER-PF250R 55 100 kw 1 250 1998~2001 55 100 kw 1 250 2001~2005 INER-PF450 1200 kw 1 450 2004~2005 100 kw 1 INER-PF1000 INER-PF3000 1500 kw 1 1,000 TBD 3,000 kw 1 3,000 TBD 20 D C / R F 1996 100 10 400~3,000 kg/cm 2 8 ~ 15 >15 kg/cm 2 > 6 1997 1, 200 I N E R - 1200 T I N E R - P F 250 55 1998 250 6 37

I N E R - P F 2 5 0 R 2001 2004 250 1, 000 ~ 2, 000 400 ~ 1, 000 1 / 5 ~ 1 / 2 27 900 200 38

5 0 2003 1 1 2004 7 3, 000 70 39

95% Binder PVA 5% 1150 100% Binder 900 50% 50% 1200 G D P G N 6 % 6. 3 % 87 % 1 983 97 % 2003 91 % 2004 1 1 4 2004 1 9 11. 9 % 9 8. 1 % 40

SOFC YSZ Da~150 nm SOFC d=10~30nm SOFC S O F C D M F S O F C 150 nm YSZ/NiO 50/50 10 ~ 30 n m 41

MWCNT TEM 670 Balance of Plant BOP 1 atm G C TO O L A i r / F u e l = 7.0 4. 0 fully external reforming 77.8 % 86.6% Steam reforming 7 65 ~ 770 75 % ~ % 100 % 97.6%~100% SOFC 300 % 1 95 % 1400 psi 3.3 wt% D M F C N a f i o n N a f i o n 117 3 P t / C N T P t - Ru/ CNT P t - Ru-Ir/ CNT D M F C 1. 5 P t ~ 2 n m M E A DMFC Stack 17 W @ 70 DMFC 3 C I I I - V I I I - V 42

I I I - V 25 % 100 19 % 10 ~ 14 % 150 W 1990 11 % INER DMFC InGaP/GaAs/Ge I-V 43

3% 2010 514 10 % 1 4. 5 % 4. 7 % 34. 9 % 41. 8 % 4 % 1 ~ 2 40 % 80 % 3 ~ 5 6 ~ 10 M W 93 100 kw S O F C 5 kw 100 5 k W S O F C 60% L E D A P C V D M O C V D L E E - g u n E v a p o r a t o r L E D 7-15 lm/w 20 lm/w 44

93 8 1 0 10 2 0 0. 037 ~ 0. 043 90 1 0 9 92 93 8 1 6 24 2 5 261 93 8 1 7 45

10 8 9 3 1 1 1 2 3 8 1 2 8 1 3 8 1 8 93 9 1 0 93 1 2 3 46

I A E A I C R P 0. 01 1 I A E A I C R P I A E A 1 996 TECDOC- 855 1998 T E C D O C - 1000 2 0 0 3 D S - 1 6 1 e x c l u s i o n e x e m p t i o n c l e a r a n c e 2004 47

8 R S - G - 1. 7 93 7 3 0 2004 I A E A 9 3 8 I A E A R S - G - 1. 7 T E C D O C - 1 0 0 0 93 12 29 94 2,500 18 5 7 29 S u r r y 20 48

70 84 85 93 99 86 88 Surry Susqhehanna 49

1944 Oak Ridge 50 SFR

100 42 92 1 2 2 5 93 1 1 6 97 102 93 7 1 5 9 4 97 L'Aube Barnwell 51

1906 4, 000 2 4 1 3. 5 6. 1-226 R a - 226 3-232 T h - 232-228 A C - 228-212 P b - 212-212 B i - 212-208 T L - 208-226 R a - 226-214 P b - 214-214 B i - 214-2 1 0 P b - 2 1 0 52

- 232 T h - 232-208 T L - 208 270-238 U - 238-214 B i - 214 44 6 1-238 U - 238-2 1 4 B i - 2 1 4-238 U - 238-232 Th-232-228 R a - 228 T1 / 2= 6. 7-224 R a - 224 T1 / 2= 3. 66-238 U - 238-226 R a - 226 T1 / 2= 1602-226 Ra-226 0. 34 1 93 8 30 0.34 53

94 9 7 3 3 95 95 95 54 2004 2004

C E A O E C D / N E A J N E S 2004 P B N C O E C D / N E A I A E A I C R P 19 19 55

2004 2 2005 Additional Pr o t o c o l 2004 4 1540 55 92 12 56

95 % 93 93 93 14 20 21 93 4 5 11 57

67 93 5 55 16 10 % 4 5 70 % 78 % 1 0 93 55 58

93 94 93 59

37 46 14 42 139 1 1 1 1 4 4 18 11 253 253 307 106 151 70 11 556 NA 44 1369 327 6/84 8/101 8/123 4/143 14/393 NA NA NA 9/41 9/41 93 93 60

93 93 43 6 1 50 26 78 93.05.31 93.07.20 93.10.15 93.12.17 1. 92 2. 92 1. 2. 3. 4. 1. 93 2. 1. 2. 12 3. 4. 61

93 93 93.06.24 93 93.12.23 1. 2. NRC IN 2003-14 Potential Vulnerability of Plant Computer Network to Worm Infection 3. 93 1 5 GCB 4. EOC-16 387A B 5. 161KV DCR 1. 2. 93 3. 4. 5. 6. NRC 10CFR50.48 c NFPA- 805 RG-1.189 93 93.06.10 93.12.15 1. RG 1.26 Rev. 3 2/76 note b ASME Code N-symbol need not be applied 2. RPV SETTING 1. 91 2. PSAR Additional Requirements 62

57 5 9 30 92 9 3 6 1 93 70 1 2 3 4 5 6 63

92 2 1 1 93 21 6 64

93 83 144 93 2 1 60 2 98 527 132 358 13,515 93 2 1 522 2 165 93 11 8 122 19 65

15 5 5 93 3 7 78 15 1 9 2 93 94 8 17 93 4 1 66

93 92 4 93 1 2 3 92 92 4 93 1 2 3 94 80 9 88 3 81 67

43 14 91 93 91 4 92 1 2 3 91 4 92 1 2 3 68

9 3 69

3 94-60 70

93 2 2 1 12 1 6 93 87 93 3 12 695 4, 026 92 2 1 2, 911 93 12 2, 202 75.6% 0.00 0.00 1 5 1 5 15 15 400 561 401 124 141 29 1656 22 93 74 25 7 4 225 0 6 13 3 29 2 53 334 44 5 0 0 0 383 0 3 3 8 1 0 15 1 11 3 8 2 0 25 0 0 0 4 94 0 98 0 0 0 63 6 0 69 71

92 1 2 2 4 55 8 94 93 6 1 6 94 ~ 95 93 7 2 1 72

G I S G P S 035 137 911 73

S 74

93 93 66 410 93 1, 2 0 0 75

19 2,210 12 93 1 93 1 1 0 4 93 8, 756 8, 688 275 4 2004 198 26 93 1 2 3 0 12 3 1 76

Reactor Oversight Pr o g r a m Significance Determination Process, SDP S D P P R i S E 6 9 12 P R i S E I N E R I S K E N I N E R F T E I N E R F T I N E R F T PRiSE 77

F S A R F S A R 2 M W 15 m 0. 6 m 0. 1 m 3. 2 m 78 P D A

G P S G P R S G I S W N 23 P S A R NRC RG 1.26 RT P S A R 79

-124-1 2 4-124 T R 30 / 15-125 - 124-125 - 125 0. 5 20 ~ 21 M e V 10 A h r -124-124 - 124 M C A 603 7 23 1 691 k e V - 124 511 k e V - 124 159 k e V - 123-123 - 125 p, 3 n Te - 124 p, 2 n - 123 5 % - 123 13. 2-124 99 % - 124 0.01N Na124I 1 ma R F 5 ma 10 80

m A Einzel lens Einzel lens R F 9 % 20-30 % 1 MeV 1 ma R F 30 MeV 1 ma [ 18 F]-FLT [ 18 F]- F D G [ 18 F]-FLT [ 18 F]-F18 L-Thymidine Tracer Lab FX-FN [ 18 F]- F LT [ 18 F]- F LT Tubingen PET Center Dr. Machulla [ 18 F]F LT Tracer Lab FX-FN [ 18 F]F LT 20 % [ 18 F]F LT F - 18 > 1Ci [ F]F LT Tracer Lab FX-FN [ 18 F]FLT [ 18 F]- F D G [ 18 F] -99m Ciprofloxacin -99m ciprofloxacin -99m ciprofloxacin 15-99m ciprofloxacin 1 4 2 4 - c o u n t e r -99m ciprofloxacin -99m ciprofloxacin 1 4 2 4 81

-99m ciprofloxacin -99m ciprofloxacin -99m ciprofloxacin -99m ciprofloxacin 67 Ga-DOTA-Tyr3-Octreotide solid-phase peptide synthesis D O TA - Ty r 3 - O c t r e o t i d e 8 ~ 10 D O TA - D - Ph e - C y s - Ty r - D - Tr p - Ly s - T h r - C y s - T h r ( o l ) D O TA - Ty r 3 - O c t r e o t i d e 12 M S D O TA - Ty r 3 - O c t r e o t i d e 5 I - Ty r 1 - S o m a t o s t a t i n ( Ki= 3.95±0.75nM) D O TA - Ty r 3 - O c t r e o t i d e 6 A R 42 J L e w i s 7 G a - D O TA - Ty r 3 - O c t r e o t i d e Micro SPECT D O TA - Tyr3-Octreotide 67 Ga-DOTA-Tyr 3 -Octreotide 3.3mCi/0.3ug AR42J Lewis 4h 8h 24h 48h Micro SPECT N y l o n P E T N y l o n P E T S E M T E M 82

Staphylococcus aureus N y l o n P E T P E T VCSEL RCLED Vertical Cavity Surface Emitting L a s e r s : V C S E L s 1977 1996 H o n e y w e l l L E D R C L E D V C S E L Spontaneous Emission L a s i n g 400 5 00 k e V 30-500 k e V < 3 A V C S E L R C L E D R C -TRIM code 25 3 5 0 V C S E L R C L E D 500keV 83

2 6 / t p d 6 B W R H E S T 84

2 / 3 93 8 9 1 1 2 1/3 50~1000 nm L a N i5 C H4 670 H RT E M S E M R a m a n S c a t t e r i n g 15~130 nm S i e v e r t 1400 psi 3.3 wt% 85

91 1 2 2 5 92 6 93 6 3 93 4 6 7 6 2 50 7 95 91 1 2 92 93 4 86

93 93 E O C - 20 E O C - 16 E O C - 17 93 664 92 765 8 6. 8 % 93-0. 337 82 87

96 173 93 7 2004 190 I A E A 2 004 8 9 3 1 2 2 9 93 1 2 55 9,257 1,032 2,917 0 6,743 1,851 1,212 0 2,986 3,580 1,282 0 6,668 25,424 2,441 97,672 9,070 10,695 475 0 34,724 42,582 8,327 97,672 93.12.31 97,711 88

93 1 2 93 1 0 93 93 85 5 93 93 89

93 3 17 5 93 9 3 1 93 8 93 1 1 93 1 0 12 6 6 90

93 012 10 5 7 3 1 1 6 3 93 7 2 7 5 9 91

MTU* 66 3,083 2,336 403 99 67 3,083 2,204 381 100 70 4,975 3,156 531 104 71 4,237 3,028 572 105 73 2,151 925 373 114 74 2,159 872 352 115 1 93.12.31 2 MTU Metric Tonnes Uranium 93 1 0 C F R 7 2 N U R E G - 1 5 3 6 N U R E G - 1 5 6 7 20 84 92

93 N R C 9 3. 03. 22 ~ 23 115 R E S R A D D&D MARSSIM T R R 067 075 016 015 W- 1 012 014 5 15 4 1 2 4 93

520 5 370 94

2,500 9 161. 9-137 - 137 23-54 - 60 1. 79 4. 49-137 22 55. 4-137 - 60-1 3 7 95

7 260 7-137 - 137-137 79 9 3 16 5 24 h t t p :// w w w. t r m c. a e c. g o v. t w 93 7, 000 1 1 96

93 413 22 2-60 1 2 4 3 20 2 1 5 17 3 1 2 498 97

1 01 2 3 92 01.09 01.13 199 01.19 01.28 02.06 02.12 02.19 02.24 93 03 3P 03.01 03.01 03.01 03.03 93 03.05 03.08 018 3 1 7 200 1 6 ~ 12 0.224 ng-teq/nm 3 0.5 ng-teq/nm 3 03.08 067 075 03.16 93 03.18~04.27 03.21~26 2004 P B N C 04 03.23~26 93 275 93 12 31 98

04.07 04.12 93 04.19~23 04.20 37 J A I F NUPEC NUMO JNES T R R 7 TRR 04.23 5 05 T R R 05.10~05.14 05.10 05.10~17 International Committee for Radionuclide Metrology ICRM Dr. Mike Woods A P M P C G P M - 68 05.11 93 05.17~21 A Kaluba Chitumbo 05.19 05.21 G M P / c G M P G M P / c G M P 05.26 93 05.28 6 05.31 99

06 06.04 06.08 06.10 06.23 06.24 93 06.25 06.28 06.28~07.02 06.30 7 07 07.06 07.06 94 97 3 3 21 7 13 07.07 07.07 93 7 7 07.14 07.20 07.20 07.20~22 ESF Response Time 07.22 07.25 07.27 93 100

8 07.28 28 07.30 08 08.04~06 10~12 08.05 93 08.12 08.16~20 08.17 08.18 08.27 9 3 9 08.30~09.03 09 93 09.02 93 09.02 09.07 09.09~10.20 09.13 09.20 93 09.21~24 09.27~10.01 09.29~10.08 101

09.30 10 8 94 ~ 95 10.04 10.04~10.08 93 10.07 10.07 10 CFR Appendix J Option B 10.14 10.15 10.15 10.18 10.18 RHR 10.19 10.19~20 24 8 10.20 26 137 11 10.29 10.29 10.29 2004 220 11.01~12.01 EOC~15 11.03~05 2004 11.17 CPD 102

12 11.22~11.26 11.23 93 11.26 11.29~30 19 35 12 23 20 19 2,110 12.02~03 A Kaluba Chitumbo 12.03 12.06~10 12.07 93 12.07 93 12.08 12.13 C A M P 12.15 12.17 12.23 93 12.27 12.27~28 93 12.29 12.29 C O O P R A 103

. 94 21x29.5 ISBN 986-00-1974-6 1. 449.061 94015473 02 82317919 80 http://www.aec.gov.tw 94 9 NT$250 10 B1 02 2578-1515 643 2 B1 04 2226-0330 GPN 1009401963 ISBN 986-00-1974-6

80 (02)8231-7919 (02)8231-7833 ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN No.80, Sec.1, Cheng Kung Rd., Yung-Ho City, Taipei County, Taiwan R.O.C. Tel : (02)8231-7919 Fax : (02)8231-7833 http : //www.aec.gov.tw 80 (02)8231-7919 (02)2232-2360 FUEL CYCLE AND MATERIALS ADMINISTRATION ATOMIC ENERGY COUNCIL No.80, Sec.1, Cheng Kung Rd., Yung-Ho City, Taipei County., Taiwan R.O.C. Tel : (02)8231-7919 Fax : (02)2232-2360 http : //fcma.aec.gov.tw 1000 (02)8231-7717 (03)4711064 INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL No.1000, Wunhua Rd.,Jiaan Village, Lung-Tan, Tao-Yuan Taiwan R.O.C. Tel : (02)8231-7717 Fax : (03)4711064 http : //www.iner.gov.tw 823 (07)3709206 (07)3701660 RADIATION MORNITORING CENTER ATOMIC ENERGY COUNCIL No.823, Cherng-Ching Rd.,Kaohsiung, Taiwan R.O.C. Tel : (07)3709206 Fax : (07)3701660 http : //www.trmc.aec.gov.tw 1009401963 ISBN 986-00-1974-6